SK pharmteco has opened its new Current Good Manufacturing Practice (CGMP) plasmid suite at its facility in King of Prussia, ...

The Fremont, California-based contract development and manufacturing organization is planning another facility north of ...

The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis ...

Engineers and biologists at Dartmouth College have found that, just like word order affects meaning in a sentence, the ...

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival ...

The North America CRISPR gene editing market is poised for substantial growth, with projections indicating a robust annual expansion of 24.4% throughout the forecast period. By 2031, it is anticipated ...

Colorado State University startup GenoFAB has joined BioMADE, connecting with over 300 organizations nationwide to advance biomanufacturing innovation. GenoFAB contributes critical expertise in ...

IntroductionThe Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 ...

As the exclusive CDMO partner for this program, Porton Advanced provided comprehensive process development and manufacturing services, including plasmid, lentiviral vectors and final CAR-T cell ...

This new service delivers clinical-grade plasmid DNA production from cell bank to batch release in three months. This can help accelerate the development of gene and cell therapies. Located to serve ...